These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions. Kokjohn TA; Roher AE Alzheimers Dement; 2009 Jul; 5(4):340-7. PubMed ID: 19560104 [TBL] [Abstract][Full Text] [Related]
28. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice. Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827 [TBL] [Abstract][Full Text] [Related]
29. Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer's disease. Li W; Pang Y; Wang Y; Mei F; Guo M; Wei Y; Li X; Qin W; Wang W; Jia L; Jia J BMC Med; 2023 Jun; 21(1):223. PubMed ID: 37365538 [TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular biology of Alzheimer's disease and animal models. Price DL; Sisodia SS Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393 [TBL] [Abstract][Full Text] [Related]
31. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition. Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121 [TBL] [Abstract][Full Text] [Related]
32. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease. Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease. Martínez-Iglesias O; Naidoo V; Carrera I; Cacabelos R Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269588 [TBL] [Abstract][Full Text] [Related]
34. Transgenic animal models for Alzheimer's disease. Fukuchi K; Ogburn CE; Smith AC; Kunkel DD; Furlong CE; Deeb SS; Nochlin D; Sumi SM; Martin GM Ann N Y Acad Sci; 1993 Sep; 695():217-23. PubMed ID: 8239285 [TBL] [Abstract][Full Text] [Related]
36. Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model. Kook SY; Jeong H; Kang MJ; Park R; Shin HJ; Han SH; Son SM; Song H; Baik SH; Moon M; Yi EC; Hwang D; Mook-Jung I Cell Death Differ; 2014 Oct; 21(10):1575-87. PubMed ID: 24853300 [TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease amyloid-β pathology in the lens of the eye. Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705 [TBL] [Abstract][Full Text] [Related]
38. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease. Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151 [TBL] [Abstract][Full Text] [Related]
39. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
40. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide. Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]